Composition for the treatment of amyotrophic lateral sclerosis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/198 (2006.01) A61K 31/185 (2006.01) A61K 31/20 (2006.01) A61K 31/201 (2006.01) A61K 31/203 (2006.01) A61K 38/04 (2006.01) A61P 21/00 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2663272

The invention relates to the use of a composition for controlling the evolution of amyotrophic lateral sclerosis, characterised in that it comprises at least: a conjugate of poly-lysine and at least one anti-oxidant, and a conjugate of poly-lysine and at least one fatty acid. The invention also relates to a particular composition for controlling the evolution of amyotrophic lateral sclerosis.

L'objet de l'invention est l'utilisation d'une composition pour maîtriser l'évolution de la Sclérose Latérale Amyotrophique, caractérisée en ce qu'elle comprend au moins : un conjugué entre la Poly-Lysine et au moins un anti-oxydant, et un conjugué entre la Poly-Lysine et au moins un acide gras. L'invention concerne également une composition particulière pour maîtriser l'évolution de la Sclérose Latérale Amyotrophique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Composition for the treatment of amyotrophic lateral sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for the treatment of amyotrophic lateral sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for the treatment of amyotrophic lateral sclerosis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1578904

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.